125 related articles for article (PubMed ID: 1334038)
1. Androgen receptor in cirrhotic liver, adenomatous hyperplastic nodule and hepatocellular carcinoma in the human.
Nagasue N; Yamanoi A; Kohno H; Kimoto T; Chang Y; Taniura H; Uchida M; Nakamura T
Hepatogastroenterology; 1992 Oct; 39(5):455-60. PubMed ID: 1334038
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease.
Lencioni R; Caramella D; Bartolozzi C; Mazzeo S; Di Coscio G
Acta Radiol; 1994 Mar; 35(2):138-42. PubMed ID: 8172738
[TBL] [Abstract][Full Text] [Related]
3. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
Terada T; Hoso M; Nakanuma Y
Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
[TBL] [Abstract][Full Text] [Related]
4. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study.
Kaji K; Terada T; Nakanuma Y
Am J Gastroenterol; 1994 Jun; 89(6):903-8. PubMed ID: 8198103
[TBL] [Abstract][Full Text] [Related]
5. [Androgen receptor in hepatocellular carcinoma and the surrounding liver tissues in China].
Liang L; Lu M; Huang J
Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):214-7. PubMed ID: 9387258
[TBL] [Abstract][Full Text] [Related]
6. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor in primary hepatocellular carcinoma and its clinical significance.
Zhang X; He L; Lu Y; Liu M; Huang X
Chin Med J (Engl); 1998 Dec; 111(12):1083-6. PubMed ID: 11263369
[TBL] [Abstract][Full Text] [Related]
8. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging.
Matsui O; Kadoya M; Kameyama T; Yoshikawa J; Arai K; Gabata T; Takashima T; Nakanuma Y; Terada T; Ida M
Radiology; 1989 Oct; 173(1):123-6. PubMed ID: 2550995
[TBL] [Abstract][Full Text] [Related]
9. [Estrogen and androgen receptors in hepatocellular carcinoma and in noncancerous liver tissue].
Hamazaki K; Miura H; Sakai H; Sato S; Yunoki M; Miichi N; Noda T; Mori M; Orita K
Gan No Rinsho; 1989 Sep; 35(10):1109-13. PubMed ID: 2550681
[TBL] [Abstract][Full Text] [Related]
10. [Significance of both nuclear and cytosol androgen receptor (AR) in assessment of AR status in prostate carcinoma and hepatocellular carcinoma].
Lu HP; Gao JH
Ai Zheng; 2003 Feb; 22(2):168-70. PubMed ID: 12600293
[TBL] [Abstract][Full Text] [Related]
11. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
[TBL] [Abstract][Full Text] [Related]
12. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
13. [Precancerous stages of hepatocellular carcinoma].
Tanikawa K
Gan To Kagaku Ryoho; 1995 Dec; 22(14):2055-61. PubMed ID: 8607615
[TBL] [Abstract][Full Text] [Related]
14. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptors in hepatocellular carcinoma and surrounding parenchyma.
Nagasue N; Ito A; Yukaya H; Ogawa Y
Gastroenterology; 1985 Sep; 89(3):643-7. PubMed ID: 2991072
[TBL] [Abstract][Full Text] [Related]
17. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.
Lee RG; Tsamandas AC; Demetris AJ
Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980
[TBL] [Abstract][Full Text] [Related]
18. Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis.
Yeh SH; Chang CF; Shau WY; Chen YW; Hsu HC; Lee PH; Chen DS; Chen PJ
Cancer Res; 2002 Aug; 62(15):4346-51. PubMed ID: 12154039
[TBL] [Abstract][Full Text] [Related]
19. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification.
Roncalli M; Roz E; Coggi G; Di Rocco MG; Bossi P; Minola E; Gambacorta M; Borzio M
Hepatology; 1999 Nov; 30(5):1174-8. PubMed ID: 10534338
[TBL] [Abstract][Full Text] [Related]
20. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
